Contemporary Trends and Outcomes Associated with the Pre-Procedural Use of Oral P2Y12 Inhibitors in Patients Undergoing Percutaneous Coronary Intervention: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)

OBJECTIVES: We sought to describe trends in the use of pre-procedural P2Y12 inhibitors and their clinical impact in patients undergoing percutaneous coronary intervention (PCI). BACKGROUND: Oral P2Y12 inhibitors are ubiquitously used medications; however, the specific timing of initial P2Y12 inhibit...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:J Invasive Cardiol
Hoofdauteurs: Sukul, Devraj, Seth, Milan, Dixon, Simon R., Khandelwal, Akshay, LaLonde, Thomas A., Gurm, Hitinder S.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2017
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5699908/
https://ncbi.nlm.nih.gov/pubmed/28420804
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items